Aurora Cannabis Inc. (NASDAQ:ACB) Sees Large Growth in Short Interest

Aurora Cannabis Inc. (NASDAQ:ACB) was the target of a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 2,810,000 shares, a growth of 6.8% from the October 15th total of 2,630,000 shares. Based on an average daily trading volume, of 1,030,000 shares, the days-to-cover ratio is currently 2.7 days. Approximately 5.2% of the shares of the stock are short sold.

Hedge Funds Weigh In On Aurora Cannabis

Institutional investors have recently bought and sold shares of the business. Virtu Financial LLC acquired a new stake in shares of Aurora Cannabis in the 1st quarter valued at $727,000. Cetera Advisors LLC acquired a new stake in shares of Aurora Cannabis in the 1st quarter valued at $59,000. Baader Bank Aktiengesellschaft increased its stake in shares of Aurora Cannabis by 121.1% in the 2nd quarter. Baader Bank Aktiengesellschaft now owns 22,789 shares of the company’s stock valued at $100,000 after buying an additional 12,481 shares during the period. TD Asset Management Inc acquired a new stake in shares of Aurora Cannabis in the 2nd quarter valued at $255,000. Finally, Headlands Technologies LLC increased its stake in shares of Aurora Cannabis by 98.8% in the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after buying an additional 37,269 shares during the period. Institutional investors own 47.63% of the company’s stock.

Aurora Cannabis Price Performance

Aurora Cannabis stock opened at $4.23 on Tuesday. The business has a 50 day simple moving average of $5.49 and a 200 day simple moving average of $5.85. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.83 and a quick ratio of 1.88. Aurora Cannabis has a one year low of $2.84 and a one year high of $9.35. The company has a market capitalization of $231.99 million, a PE ratio of -5.57 and a beta of 1.87.

Aurora Cannabis Company Profile

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.